A registry-based modified IDEAL stage 2b evaluation of urological procedures performed using the versius robotic surgical system.

The IDEAL stage 1/2a study demonstrated feasibility of the use of the Versius robotic platform at a single institution. This multi-center collaborative modified stage 2b study adds wider exploration assessing surgical, oncologic and functional outcomes in patients undergoing urological procedures with the Versius. Data were collected from a prospective registry. Surgical outcomes were cross-checked from electronic patient records held at each hospital included in the study. All UK-based centers performing urological procedures using the Versius robot. All patients who underwent a robotic procedure using the Versius robot since inception to Jan 2023. Five UK hospitals have undertaken a total of 70 urological procedures using the Versius (Table 1). Device failure occurred in one of the cases requiring conversion to laparoscopy and a further case required conversion to open due to intra-operative complication (2/70, 2.9%). One positive margin was observed in a robotic prostatectomy patient (12.5%). Immediate continence was achieved in 4 of 8 (50%) after prostatectomy. Eight patients (11.4%) had complications within 30 days, and three were Clavien-Dindo class 3 and one class 4. A range of urological procedures were shown to be feasible and safe using the Versius across multiple sites.